drugset / Trial / NCT02586129
Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized, double-blind, active-controlled, multicenter phase 3 trial to evaluate the safety and efficacy of YH14755 in subjects with dyslipidemia and Type II Diabetes.
Timeline
- Start
- 2015-11-04
- Primary completion
- 2017-07-07
- Completion
- 2017-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 1500 mg | Oral |
| Comparator | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | YH14755 | Unknown | — | Oral |